Furthermore, the non-beneficial effects of LDR-mediated PYCR1 activation on insulin resistance were reversed after knockdown of PYCR1 expression in liver and adipose cells, indicating the key role of PYCR1 and its derived downstream insulin signalling pathway in mediating HFD-induced metabolic dysfunction. The gene discussed is PYCR1; the disease is Insulin resistance.